#RBQMLive21
RBQM 2021 On-Demand
Day One Sessions
Day Two Sessions
![](https://rbqmlive.com/wp-content/uploads/2018/10/Ken-Getz-Headshot-268x268.png)
Powered by the Pandemic – How Pharma Has Succeeded and How It Will Continue to Embrace Operational Changes Facilitated by COVID-19
with Ken Getz, Professor, Tufts Center for the Study of Drug Development.
![](https://rbqmlive.com/wp-content/uploads/2018/10/Untitled-design-24-268x268.png)
The Evolution from RBM to RBQM – How Far Have Risk-Based Approaches Come in 10 Years and Where Do We Go Next?
with Jonathan Rowe, Head of R&D Quality and Risk Management, ZS Associates.
![](https://rbqmlive.com/wp-content/uploads/2021/03/Untitled-design-18-268x268.png)
Critical Processes, Critical Data and Critical Thinking. An RBQM Implementation Journey
with Nick May, Global Risk-Based Monitoring Strategic Lead, Parexel.
![](https://rbqmlive.com/wp-content/uploads/2021/03/Untitled-design-7-268x268.png)
The Application of RBQM to Rare Disease and Small Trials
with Jacqueline Gough, Director, Central Monitoring, Alexion Pharmaceuticals.
![Panel Discussion](https://rbqmlive.com/wp-content/uploads/2021/03/Untitled-design-19-268x268.png)
RBQM Best Practice Defined by Leading Industry Working Groups
with Nicole Stansbury, Syneos, Steve Young, CluePoints, Linda Sullivan, MCC, and, Ann Meeker O'Connell, Vertex Pharmaceuticals.
![](https://rbqmlive.com/wp-content/uploads/2018/10/Untitled-design-26-268x268.png)
The Future of Clinical Trials is Now
with Sy Pretorius, President, Clinical Development and Chief Medical Officer, Parexel.
![](https://rbqmlive.com/wp-content/uploads/2018/10/Untitled-design-20-268x268.png)
Paving the Way for Centralized Monitoring Success at Pfizer
with Lynne Cesario, Global Risk-Based Monitoring Program Lead, Pfizer.
![Panel Discussion](https://rbqmlive.com/wp-content/uploads/2021/03/Untitled-design-19-268x268.png)
Applying the Principles of RBQM to Data Management
with Steve Young, Chief Scientific Officer, CluePoints, and Patrick Nadolny, Global Head, Clinical Data Management, Sanofi.
![](https://rbqmlive.com/wp-content/uploads/2021/03/Untitled-design-15-268x268.png)
2030: An RBQM Odyssey - RBQM in Clinical Trials of the Future
Lukasz Bojarski, Head of Centralized Monitoring, AstraZeneca.
![Panel Discussion](https://rbqmlive.com/wp-content/uploads/2021/03/Untitled-design-19-268x268.png)
Has RBQM Lived up to TransCelerate's Expectations? Ask the Experts!
with Brett Wilson, Pfizer, Jacqueline Gough, Alexion, Stephanie Clark, Janssen, Mary Arnould, Astellas, and Esther Huffman-O'Keefe, Regeneron.